HSPA9 and ovarian carcinoma: Meanwhile, researchers discovered that the overexpression of HSPA9/GRP75 notably enhanced macropinocytosis in ovarian cancer cells, thereby synergizing with Tat-pDNA-Ca2+ nanoparticles to significantly amplify the cytotoxic effects on tumor cells.